Effect of Green Tea on Treatment of Lupus
The Effect of Green Tea Extract on Some Inflammatory Biomarkers(IL 6, IL1β,TNF α,CRP), Serum Total Antioxidant Capacity(TAC), MDA and Disease Activity in Patients With Systemic Lupus Erythematous
Sponsor: Ahvaz Jundishapur University of Medical Sciences
Listed as NCT02875691, this PHASE2 trial focuses on Autoimmune and Lupus Erythematosus, Systemic and remains completed. Sponsored by Ahvaz Jundishapur University of Medical Sciences, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ahvaz Jundishapur University of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Shiraz, Iran